TFF Pharmaceuticals, Inc. TFFP
Set alert
At close · Dec 12
52-week range unavailable
- Open
- 0.0902
- Prev close
- 0.065
- Mkt cap
- 288.80K
- Vol
- 11.02M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0611
- High
- 0.0902
- Forward P/E
- -0.02
- Beta
- 1.32
- Short ratio
- 1.77
- Inst. own
- 24.37%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.15
- 200-d avg
- 2.39
- 1y target
- 0.00
Discussion (24)
Sign in to join the discussion
VICKY HANUKA TFFP 3 years ago #1Merge is happening October 9 don’t miss it
VICKY HANUKA TFFP 3 years ago #2DRUG PIPELINE
ANALYST RATINGS
INSIDER TRADES
NEWS
$0.71
+0.04 (+5.97%)
PREVIOUS CLOSE
0.67
OPEN
0.65
52 WEEK LOW
0.53
52 WEEK HIGH
6.73
MARKET CAP
$26M
SHARES
36M
FLOAT
36M
ENTERPRISE VALUE
$11M
VOLUME
243K
AV. DAILY VOLUME
146K
COMPANY CASH DATABASE
LIVE CASH EST
$10.05M
CASH BURN
-$1.45M
NO. MTHS CASH
6.95
INSIDERS %
0.7
TOTAL DEBT TO EQUITY
0.01
BIOTECH EARNINGS CALENDAR
EARNINGS DATE
05/11/2023
EPS EST.
-0.230
EPS PRIOR.
-0.330
EPS
-0.190
REV GUIDANCE
$67.44K
VICKY HANUKA TFFP 3 years ago #3Upcoming TFFP Catalysts
DRUG
STAGE
CATALYST DATE
Voriconazole Inhalation Powder - (VORI)
Invasive Pulmonary Aspergillosis (IPA)
Phase 2
2023
Phase 2 trial data reported that previously intolerant to oral voriconazole therapy successfully treated with TFF VORI, noted September 8, 2022. Phase 2 trial data showed that second patient treated to clinically benefit from administration in compassionate use program, noted November 1, 2022. Phase 2 data due in 2023.
Tacrolimus Inhalation Powder
Lung transplant (post)
Phase 2
2Q 2023
Phase 2 trial initiated, noted May 11, 2022. Phase 2 data due in 2Q 2023.
VICKY HANUKA TFFP 3 years ago #4HARE
Kirk Allen Coleman Chief Financial Officer 09/03/2023 Buy Stock 12K 326.53% $0.79 $9,457.20 15.68K
Harlan F Weisman Director 09/03/2023 Buy Stock 150K 232.14% $0.88 $131,835.00 214.62K
Zamaneh Mikhak Chief Medical Officer 09/03/2023 Buy Stock 15K 0% $0.82 $12,300.00 15K
Stephen Rocamboli Director 09/03/2023 Buy Stock 13K 433.33% $0.80 $10,432.50 16K
Aaron G.L. Fletcher Director 21/11/2022 Buy Option 1.29 21.74K 0% $0.00 $0.00 21.74K
Aaron G.L. Fletcher Director 21/11/2022 Buy Stock 43.47K 43.47% $1.15 $49,990.50 143.47K
Well, I think I’m done playing games with $TFFP.
Not sure what to think of $TFFP anymore. ??♂️
I just averaged down...gonna keep averaging down $TFFP
Bought back in bud way too high, such a terrible trader lol $TFFP I have faith she’s going over 20 by EOY
I playing this so terrible the last 2 days...$TFFP been holding since 13 sold yesterday for EV plays at 16.98 and of course she pops
Errrrt this thing is bipolar $TFFP